TITAN BIOTECH Financial Statement Analysis
|
||
|
The Revenues of TITAN BIOTECH have increased by 13.94% YoY .
The Earnings Per Share (EPS) of TITAN BIOTECH has decreased by -13.34 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
TITAN BIOTECH Last 5 Annual Financial Results
[BOM: 524717]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹164 Cr | ₹144 Cr | ₹124 Cr | ₹14,223,723 Cr | ₹79 Cr |
| Expenses | ₹130 Cr | ₹114 Cr | ₹92 Cr | ₹9,605,092 Cr | ₹66 Cr |
| Operating Profit (Excl OI) | ₹34 Cr | ₹30 Cr | ₹31 Cr | ₹4,618,631 Cr | ₹13 Cr |
| Other Income | ₹1.75 Cr | ₹1.94 Cr | ₹0.94 Cr | ₹78,841 Cr | ₹0.45 Cr |
| Interest | ₹1.17 Cr | ₹0.75 Cr | ₹0.87 Cr | ₹172,744 Cr | ₹2.35 Cr |
| Depreciation | ₹3.33 Cr | ₹2.60 Cr | ₹2.37 Cr | ₹221,731 Cr | ₹1.80 Cr |
| Profit Before Tax | ₹32 Cr | ₹28 Cr | ₹29 Cr | ₹4,270,556 Cr | ₹10 Cr |
| Profit After Tax | ₹24 Cr | ₹21 Cr | ₹22 Cr | ₹3,170,529 Cr | ₹7.84 Cr |
| Consolidated Net Profit | ₹25 Cr | ₹25 Cr | ₹22 Cr | ₹3,033,521 Cr | ₹7.07 Cr |
| Earnings Per Share (Rs) | ₹26.06 | ₹30.07 | ₹30.06 | ₹26.24 | ₹36.71 |
| PAT Margin (%) | 11.68 | 14.42 | 14.60 | 17.55 | 22.29 |
| ROE(%) | 12.74 | 19.45 | 21.44 | 27.98 | 58.74 |
| ROCE(%) | 17.00 | 25.39 | 27.40 | 33.74 | 60.80 |
| Total Debt/Equity(x) | 0.01 | 0.05 | 0.06 | 0.09 | 0.21 |
Key Financials |
||
| Market Cap | : | ₹ 822.6 Cr |
| Revenue (TTM) | : | ₹ 174.3 Cr |
| Net Profit(TTM) | : | ₹ 20.6 Cr |
| EPS (TTM) | : | ₹ 24.8 |
| P/E (TTM) | : | 40.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| TITAN BIOTECH | 4% | -24.1% | 7.3% |
| PIDILITE INDUSTRIES | 0.3% | -2% | -5.4% |
| SRF | -2.2% | -6.7% | 26.5% |
| SOLAR INDUSTRIES INDIA | 3.6% | -0.5% | 35.7% |
| GUJARAT FLUOROCHEMICALS | -0.4% | -2.3% | -13.4% |
| GODREJ INDUSTRIES | 0.5% | 0.3% | 6.9% |
| DEEPAK NITRITE | 1.1% | -1% | -35.7% |
| TATA CHEMICALS | -0.9% | -8.6% | -23.5% |
| HIMADRI SPECIALITY CHEMICAL | 0.7% | -2.5% | -17.6% |
TITAN BIOTECH Revenues
[BOM: 524717]
| Y-o-Y | 13.94 % |
| 5 Yr CAGR | 19.88 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹164 Cr | 13.94 | |
| Mar2024 | ₹144 Cr | 16.55 | |
| Mar2023 | ₹124 Cr | -100.00 | |
| Mar2022 | ₹14,223,723 Cr | 17,905,338.91 | |
| Mar2021 | ₹79 Cr | - | |
TITAN BIOTECH Operating Profit
[BOM: 524717]
| Y-o-Y | 16.13 % |
| 5 Yr CAGR | 26.26 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 16.13 | |
| Mar2024 | ₹30 Cr | -5.60 | |
| Mar2023 | ₹31 Cr | -100.00 | |
| Mar2022 | ₹4,618,631 Cr | 34,242,419.18 | |
| Mar2021 | ₹13 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.90 % |
| 5 Yr CAGR | 5.32 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 20.89% | 1.90 | |
| Mar2024 | 20.5% | -19.00 | |
| Mar2023 | 25.31% | -22.05 | |
| Mar2022 | 32.47% | 91.22 | |
| Mar2021 | 16.98% | - | |
TITAN BIOTECH Profit After Tax
[BOM: 524717]
| Y-o-Y | 0.04 % |
| 5 Yr CAGR | 36.95 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 0.04 | |
| Mar2024 | ₹25 Cr | 14.57 | |
| Mar2023 | ₹22 Cr | -100.00 | |
| Mar2022 | ₹3,033,521 Cr | 42,931,134.93 | |
| Mar2021 | ₹7.07 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -19.00 % |
| 5 Yr CAGR | -14.92 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.68 % | -19.00 | |
| Mar2024 | 14.42 % | -1.23 | |
| Mar2023 | 14.6 % | -16.81 | |
| Mar2022 | 17.55 % | -21.27 | |
| Mar2021 | 22.29 % | - | |
TITAN BIOTECH Earnings Per Share (EPS)
[BOM: 524717]
| Y-o-Y | -13.34 % |
| 5 Yr CAGR | -8.21 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 | -13.34 | |
| Mar2024 | ₹30 | 0.03 | |
| Mar2023 | ₹30 | 14.56 | |
| Mar2022 | ₹26 | -28.52 | |
| Mar2021 | ₹37 | - | |
TITAN BIOTECH Return on Capital Employed (ROCE)
[BOM: 524717]
| Y-o-Y | -33.04 % |
| 5 Yr CAGR | -27.28 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 17% | -33.04 | |
| Mar2024 | 25.39% | -7.34 | |
| Mar2023 | 27.4% | -18.79 | |
| Mar2022 | 33.74% | -44.51 | |
| Mar2021 | 60.8% | - | |
TITAN BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹991.1 |
| Current MarketCap | : | ₹ 822.6 Cr |
| Updated EOD on | : | Nov 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TITAN BIOTECH | 4% |
-24.1% |
7.3% |
| SENSEX | 1.6% |
2.7% |
6.3% |
TITAN BIOTECH related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about TITAN BIOTECH Financials
How the annual revenues of TITAN BIOTECH have changed ?
The Revenues of TITAN BIOTECH have increased by 13.94% YoY .
How the Earnings per Share (EPS) of TITAN BIOTECH have changed?
The Earnings Per Share (EPS) of TITAN BIOTECH has decreased by -13.34 % YoY .
Check out Intrinsic Value of Peers of TITAN BIOTECH
Compare Stock Analytics of Peers of TITAN BIOTECH
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
